FINWIRES · TerminalLIVE
FINWIRES

Fed Could Soon Drop Implied Easing Bias, Stifel Says

作者

-- The Federal Reserve's most recent policy statement had an implied easing bias, but that could soon be removed amid a growing divide among policymakers over the direction of interest rates, Stifel said in a note Thursday.

The Federal Open Market Committee left interest rates unchanged on Wednesday, marking its third consecutive pause.

"In considering the extent and timing of additional adjustments to the target range for the federal funds rate, the committee will carefully assess incoming data, the evolving outlook, and the balance of risks," the FOMC said, sticking to its stance from March.

That suggests a lingering bias toward rate cuts, Stifel Chief Economist Lindsey Piegza wrote.

But the decision wasn't unanimous. Fed Governor Stephen Miran favored a rate cut, while three officials opposed including an easing bias in the statement. That pushed the ratio of dissents to the highest since 1992, Piegza said.

"While the Fed did not adjust the statement to move from an easing bias to a neutral stance as of yet, several Fed officials voiced support for doing so, suggesting such an adjustment may be coming sooner than later," Piegza said.

"At the very least, the cohort of dissents sends a signal to both the market and new leadership that many agree the data do not support any additional accommodation at this point, and furthermore, any push to implement such will potentially face fierce opposition."

The Senate Banking Committee on Wednesday advanced Kevin Warsh's nomination as Fed chair to the Republican-controlled Senate. Warsh is President Donald Trump's pick to replace Jerome Powell, whose term as Fed chief expires on May 15.

Powell said he will stay on as a Fed governor after his chairmanship ends.

The FOMC pointed out "elevated" inflation amid higher energy prices. Last month, the Fed described inflation as "somewhat elevated."

相關文章

Asia

瑞思邁公佈第三財季非GAAP獲利及營收均有所成長

瑞思邁(ResMed,ASX:RMD)週五公佈了2025財年第三季非GAAP每股收益為2.86澳元,高於去年同期的2.37澳元。 FactSet調查的分析師此前預期每股收益為2.80澳元。 截至3月31日的三個月內,公司營收為14.3億澳元,高於去年同期的12.9億澳元。 FactSet調查的分析師先前預期營收為14.2億澳元。 公司預計2026財年非GAAP毛利率將介於62%至63%之間。 董事會宣布發放季度股息,每股0.60澳元,高於去年同期的0.53澳元,將於6月18日支付給截至5月14日登記在冊的股東。

$ASX:RMD
Research

研究快訊:Bio:儘管銷售額/利潤率大幅下降,但第一季業績仍高於預期

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:BIO公佈的第一季業績顯示,其兩大業務部門均面臨壓力。營收為5.921億美元,年增1.1%(較市場預期高出約300萬美元),但以固定匯率計算下降4.2%。調整後每股收益為1.89美元,年減25.6%,但比市場預期高出0.10美元。營業利益率從上年同期的10.8%下降420個基點至6.6%。生命科學和臨床診斷業務板塊均出現以固定匯率計算的下滑,主要原因是學術界持續疲軟以及中東衝突的影響。管理階層下調了2026年業績預期,預計以固定匯率計算,營收成長率為-3.0%至+0.5%(先前預期為+0.5%至+1.5%),營業利潤率為10.0%至12.0%(先前預期為12.0%至12.5%)。儘管面臨營運方面的挑戰,BIO仍維持了強勁的現金流,自由現金流達7,810萬美元,回購了約17.6萬股股票。我們認為,公司資產負債表依然穩健,擁有15.6億美元的現金和短期投資,使其在充滿挑戰的市場環境下仍具備財務彈性。

$BIO
Research

研究快訊:Arthur J. Gallagher 第一季收購相關營收強勁成長

獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:AJG第一季調整後每股盈餘為4.47美元,高於去年同期的3.72美元,低於我們先前4.56美元的預期,但高於市場普遍預期的4.43美元。第一季營收成長28%,超過我們先前12%-18%的預期,主要得益於收購,但公司整體5%的內生成長低於我們先前7%-10%的預期。我們認為AJG是業界整合能力較強的公司之一,但投資人對這種收購策略固有的執行風險日益擔憂。管理階層依然保持樂觀,並強調本季是AJG連續第24季實現兩位數的調整後EBITDAC成長。第一季利潤率表現喜憂參半。受上年同期AssuredPartners融資收益的影響,經紀業務調整後EBITDAC利潤率下降320個基點至40.1%;而風險管理業務利潤率則上升130個基點至21.7%。 AJG第一季完成9項收購,總價值5,900萬美元,而上年同期完成11項收購,總價值1.01億美元。我們預計,收購仍將是AJG未來成長策略的核心。

$AJG